Check out the top stories from last month www.statnews.com/stat-plus Check out last month's top stories. If you like what you see, join the STAT+ community today — and enjoy 25% off your first year. HYACINTH EMPINADO FOR STAT HEALTH TECH ‘This is pharma’s dream’: How drugmakers are turning telehealth into a marketing gold mine by Katie Palmer MOLLY FERGUSON FOR STAT SPECIAL REPORT Minimal compliance, or meaningful change? Epic faces a crossroads as new rules put pressure on health data sharing by Casey Ross and Mohana Ravindranath ADOBE INSURANCE Health insurers are painting a misleading picture of Medicare Advantage savings, experts say by Bob Herman More stories: After early wins, CRISPR gene editing is about to get a lot harder by Jason Mast Biotech turns to new and strange viruses to overcome gene therapy’s limitations by Jason Mast Tobacco giant Philip Morris is investing billions in health care. Critics say it’s peddling cures for its own poison by Olivia Goldhill For the ‘godfather’ of biotech, saving Biogen is the final act of a singular career by Damian Garde Doctors, seniors groups flag concerns with Medicare Advantage by Bob Herman Experts urge Medicare to overhaul secretive panel that helps determine doctors’ pay by Bob Herman Why Illumina has a merger mess of its own making by Matthew Herper Subscribe now to enjoy 25% off your first year. SUBSCRIBE Saturday, October 8, 2022 1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser
No comments